Literature DB >> 17660226

Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.

Karin Weissenborn1, Björn Ahl, Daniela Fischer-Wasels, Joerg van den Hoff, Hartmut Hecker, Wolfgang Burchert, Herbert Köstler.   

Abstract

BACKGROUND: Hepatic encephalopathy is considered to be mainly caused by increased ammonia metabolism of the brain. If this hypothesis is true, cerebral glucose utilisation, which is considered to represent brain function, should be closely related to cerebral ammonia metabolism. The aim of the present study was to analyse whether cerebral ammonia and glucose metabolism in cirrhotic patients with early grades of hepatic encephalopathy are as closely related as could be expected from current hypotheses on hepatic encephalopathy.
METHODS: (13)N-ammonia and (18)F-fluorodesoxyglucose positron emission tomography, magnetic resonance imaging and magnetic resonance spectroscopy (MRS) were performed in 21 cirrhotic patients with grade 0-1 hepatic encephalopathy. Quantitative values of cerebral ammonia uptake and retention rate and glucose utilisation were derived for several regions of interest and were correlated with the MRS data of the basal ganglia, white matter and frontal cortex.
RESULTS: A significant correlation between plasma ammonia levels and cerebral ammonia metabolism, respectively, and MRS alterations could be shown only for white matter. In contrast, MRS alterations in all three regions studied were significantly correlated with the glucose utilisation of several brain regions. Cerebral ammonia and glucose metabolism were not correlated.
CONCLUSION: Increase of cerebral ammonia metabolism is an important but not exclusive causal factor for the development of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660226      PMCID: PMC2095692          DOI: 10.1136/gut.2006.110569

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics.

Authors:  Alan H Lockwood; Karin Weissenborn; Martin Bokemeyer; U Tietge; Wolfgang Burchert
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

2.  Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.

Authors:  L Spahr; F Vingerhoets; F Lazeyras; J Delavelle; R DuPasquier; E Giostra; G Mentha; F Terrier; A Hadengue
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

Review 3.  Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies.

Authors:  Roger F Butterworth
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

4.  Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.

Authors:  Björn Ahl; Karin Weissenborn; Jörg van den Hoff; Daniela Fischer-Wasels; Herbert Köstler; Hartmut Hecker; Wolfgang Burchert
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

5.  Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.

Authors:  Dieter Häussinger
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

6.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

7.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

8.  Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis.

Authors:  Sherzad Balata; Steven W M Olde Damink; Karen Ferguson; Ian Marshall; Peter C Hayes; Nicolaas E p Deutz; Roger Williams; Joanna Wardlaw; Rajiv Jalan
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 9.  1H magnetic resonance in the study of hepatic encephalopathy in humans.

Authors:  Juan Córdoba; Francesc Sanpedro; Juli Alonso; Alex Rovira
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

10.  Correlation between ammonia levels and the severity of hepatic encephalopathy.

Authors:  Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

View more
  22 in total

1.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

2.  Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.

Authors:  Annemarie Goldbecker; Ralph Buchert; Georg Berding; Martin Bokemeyer; Ralf Lichtinghagen; Florian Wilke; Björn Ahl; Karin Weissenborn
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-10       Impact factor: 6.200

3.  (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

Authors:  Konstantinos John Dabos; John Andrew Parkinson; Ian Howard Sadler; John Nicholas Plevris; Peter Clive Hayes
Journal:  World J Hepatol       Date:  2015-06-28

4.  Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI.

Authors:  Xiao-Fei Lv; Min Ye; Lu-Jun Han; Xue-Lin Zhang; Pei-Qiang Cai; Gui-Hua Jiang; Ying-Wei Qiu; Shi-Jun Qiu; Yao-Pan Wu; Kai Liu; Zhen-Yin Liu; Pei-Hong Wu; Chuan-Miao Xie
Journal:  Metab Brain Dis       Date:  2013-07-09       Impact factor: 3.584

Review 5.  Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

Authors:  Andy Liu; Ryan B Perumpail; Radhika Kumari; Zobair M Younossi; Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2015-12-18

Review 6.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

7.  Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.

Authors:  Manoj K Sarma; Amir Huda; Rajakumar Nagarajan; Charles H Hinkin; Neil Wilson; Rakesh K Gupta; Enrique Frias-Martinez; James Sayre; Barry Guze; Steven-Huy Han; M Albert Thomas
Journal:  Metab Brain Dis       Date:  2011-06-23       Impact factor: 3.584

8.  Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.

Authors:  Andrés Duarte-Rojo; José Estradas; Roberto Hernández-Ramos; Sergio Ponce-de-León; Juan Córdoba; Aldo Torre
Journal:  Dig Dis Sci       Date:  2011-04-03       Impact factor: 3.199

Review 9.  Update on cerebral uptake of blood ammonia.

Authors:  Michael Sørensen
Journal:  Metab Brain Dis       Date:  2013-03-13       Impact factor: 3.584

10.  Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure.

Authors:  Paul E Sijens; Heyder Alkefaji; Roelineke J Lunsing; Francjan J van Spronsen; Linda C Meiners; Matthijs Oudkerk; Henkjan J Verkade
Journal:  Eur Radiol       Date:  2008-05-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.